Pilot Investigation of Stem Cells in Stroke "PISCES"

Active, not recruiting

Phase 1 Results N/A

Summary of Purpose

The study is designed to test the safety of a manufactured neural stem cell line (CTX cells) delivered by injection into the damaged brains of male patients 60 years of age or over who remain moderately to severely disabled 6 months to 5 years following an ischemic stroke. In addition the trial will evaluate a range of potential efficacy measures for future trials. Treatment will involve a single injection of one...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 31 May 2016.

1 Jun 2010 9 Jun 2010 1 Mar 2015 1 Mar 2023 1 May 2016 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Conditions

Sponsors

Trial Design

  • Allocation: Non-Randomized
  • Masking: Open Label
  • Purpose: Treatment
  • Endpoint: Safety Study
  • Intervention: Single Group Assignment

Contacts